BIOLINERX
RSS
RSS
| Careers | Contact Us
search

Investor relations home

BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel.
The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.

BioLineRx's close ties with universities, research institutes, academic institutions, technology transfer offices and biotech... More >>

Therapeutic pipeline
Title
Download Documentation Pipeline
Upcoming events
DateTitle
10/18/14
through
10/22/14
BioLineRx will present BL-7040 program (an orally available oligonucleotide for the treatment of inflammatory bowel disease) at the UEG Week 2014, October 18-22, 2014 in Vienna, Austria
01/12/15
BioLineRx to attend the JP Morgan Financial 33rd Annual Healthcare Investor Conference in San Francisco, CA, to be held during week of January 12, 2015
01/12/15
through
01/14/15
BioLineRx to present at Biotech Showcase January 12-14, 2015
What's new
DateTitle
10/21/14
Download Documentation BioLineRx Company presentation
08/27/14
Download Documentation BioLineRx AGM Proxy Statement
08/27/14
Download Documentation BioLineRx AGM Proxy Card
08/06/14
Download Documentation Second Quarter 2014 Earnings Presentation
Get help downloading or viewing the above file types